11


  Table of Contents


Forward Looking Statements

Some of the statements contained in this Form 10-K that are not historical facts are "forward-looking statements" which can be identified by the use of terminology such as "estimates," "projects," "plans," "believes," "expects," "anticipates," "intends," or the negative or other variations, or by discussions of strategy that involve risks and uncertainties. We urge you to be cautious of the forward-looking statements, that such statements, which are contained in this Form 10-K, reflect our current beliefs with respect to future events and involve known and unknown risks, uncertainties, and other factors affecting our operations, market growth, services, products, and licenses. No assurances can be given regarding the achievement of future results, as actual results may differ materially as a result of the risks we face, and actual events may differ from the assumptions underlying the statements that have been made regarding anticipated events. Factors that may cause actual results, our performance or achievements, or industry results, to differ materially from those contemplated by such forward-looking statements include without limitation:

1. Our ability to attract and retain management and key employees;

2. Our ability to generate customer demand for our products;

3. The intensity of competition; and

4. General economic conditions.

All written and oral forward-looking statements made in connection with this Form 10-K that are attributable to us or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. Given the uncertainties that surround such statements, you are cautioned not to place undue reliance on such forward-looking statements.




Overview


Description of Business

General Information

EOS Inc. ("we," "us," "our," or the "Company") was incorporated in the State of Nevada on April 3, 2015.

On or about November 18, 2016, the Company formed EOS INC. TAIWAN BRANCH, a Taiwanese corporation ("EITB") and the Company owns 100% of EITB. Yu-Cheng Yang, a shareholder and director of the Company, is the sole director of EITB. Yu-Hsiang Chia is the branch manager of EITB.

Emperor Star International Trade Co., Ltd., ("Emperor Star"), was incorporated on November 16, 2015 under the laws of Taiwan. Emperor Star is in the business of marketing and distributing various consumer products, including detergents, nutrition supplements, and skin care products.

On May 3, 2017, the Company entered into and closed a Share Purchase and Sale Agreement (the "Purchase Agreement") with Emperor Star to acquire all issued and outstanding shares of Emperor Star in consideration of $30,562 in cash. As a result of the transaction, Emperor Star became the Company's wholly owned subsidiary. Upon consummation of the transaction, the Company has assumed the business of Emperor Star and ceased to be a shell company. Yu-Hsiang Chia currently serves as the officer and director of Emperor Star. On May 26, 2020, EOS Inc. increased its investment in Emperor Star by $134,004 (NTD$4,000,000). The Company also received the contributions to Emperor Star from non-controlling interests in the amount of $33,398 (NTD$1,000,000). As a result, the Company owns 83% equity interest of Emperor Star as of June 30, 2020, which is no longer a wholly-owned subsidiary.

On September 20, 2018, the Company set up another wholly-owned subsidiary, EOS International Inc. ("EOS(BVI)"), under the laws of British Virgin Islands. EOS(BVI) is in the business of marketing and distribution of various products, including nutrition supplements, skin care products, and water purifying machines. On March 1, 2019, EOS(BVI) set up a wholly-owned subsidiary, Shanghai Maosong Co., Ltd ("Maosong"), under the laws of People's Republic of China. Maosong is in the business of marketing and distribution of various products, including nutrition supplements, skin care products, and water purifying machines in China. As of the date of this report, Maosong has a registered capital of USD $100,000, but no capital has actually been paid into Maosong.




 12


  Table of Contents

We have never been a party to any bankruptcy, receivership or similar proceeding, nor have we undergone any material reclassification, merger, consolidation, purchase or sale of a significant amount of assets not in the ordinary course of business.

We do not own any real property. Our principal executive office is presently located at 7F.-1, No. 162, Sec. 2, Zhongshan N. Rd., Zhongshan District, Taipei City 10452, Taiwan (Republic of China). EITB and Emperor Star operate from this Taipei location. Taiwan. Emperor Star and EITB entered into the office leases which commenced on June 15, 2019 and will end on June 14, 2022. The office occupies approximately 1,388 square feet and the average amount of office rent (including the maintenance fees) is approximately $2,016 per month. Before this location, our former principal executive office was at 372 Linsen N. Road, Suite 519, Zhongshan District, Taipei City, 104, Taiwan. Our then monthly rent for that office space was $1,280 and that lease expired on June 30, 2019. General Business Overview

EOS Inc. markets and distributes a variety of consumer products selected based
on its understanding of the demand for each of its products. EOS conducts its
business primarily in Asia, including the People's Republic of China ("PRC"),
Taiwan, Singapore and Malaysia. The principal products that EOS markets and
sells through its subsidiaries include Nine Layer Transformation Hair Cream,
Deep Seawater Mineral Extract, and Lifegenes & Youthgenes. Nine Layer
Transformation Hair Cream is hair-coloring product that darkens the user's hair
color to brown or black while nourishing the hair. Deep Seawater Mineral Extract
is a dietary supplement that is designed to enhance the overall health and
appearance of the consumer. Both Lifegenes and Youthgenes are dietary
supplements designed to improve the consumer's health. In addition to the four
major products, EOS also sells and distributes other dietary supplements and
skin care products from time to time as it deems profitable. During the year
ended December 31, 2021 and 2020, the net sales of dietary supplements and skin
care products were $68
,
840 and $73,317, which represented approximately 13.28% and 3.78% of the total
net sales for that period, respectively.

On April 30, 2018, we, through our Emperor Star, started purchasing a type of water purifying machines from Cosminergy Hitech Development Co., Ltd. ("Cosminergy") and reselling the water purifying machines in certain Asian areas and countries. The sales generated from selling the water purifying machines for the year ended December 31, 2021 and 2020 were $107,826 and $1,376,795, respectively, accounting for approximately 20.80% and 71.05% of the total revenue of the said period, respectively.

In November 2019, we started the marketing, promotion, sales and distribution of certain electrical noise suppressing device (the "Calibrator") globally provided by Ultra Velocity Technology Ltd. ("Ultra Velocity"), a corporation formed under the laws of Taiwan, based on an exclusive patent licensing and distribution agreement (the "Ultra Velocity Agreement") between Ultra Velocity and us. However, due to the outbreak of coronavirus ("COVID-19") in mainland China, Ultra Velocity and we terminated the Ultra Velocity Agreement in March 2020 and intended to redefine the cooperation model between the respective parties. During the year ended December 31, 2021 and 2020, the net sales of calibrator were $305,868 and $400,061. which represented approximately 58.99% and 20.65% of the total net sales for that period, respectively.

In addition, we provided inventory, membership and business management software that designed by CKS Information Co., Ltd. to our customers in the fiscal year of 2019. During the year ended December 31, 2021 and 2020, the software business line generated $35,953 and $87,613 respectively, accounting for approximately 6.93% and 4.52% of the total net sales for that period, respectively.



 13


  Table of Contents

Acquisition of Control Interest in A-Best

On August 7, 2019, the Company, A-Best Wire Harness & Components Co., Ltd ("A-Best"), a company formed under the laws of Taiwan, and Ing-Ming Lai, a Taiwanese individual and the majority shareholder of A-Best, entered into a purchase agreement (the "Purchase Agreement"), pursuant to which, subject to the terms and conditions therein, the Company shall purchase thirty-one percent (31%) of the issued and outstanding equity interest in A-Best and as consideration, issue ten million (10,000,000) shares (the "Stock Consideration") of its common stock (the "Common Stock") to Ing-Ming Lai and pay Ing-Ming Lai fifty-five million (55,000,000) new Taiwanese dollars ("NTD") (the "Cash Consideration"). The Company currently owns twenty percent (20%) of equity securities in A-Best, and will subsequently own a total of fifty-one percent (51%) of issued and outstanding A-Best shares when Ing-Ming Lai completes transferring his 31% of A-Best's equity to the Company in accordance with the Purchase Agreement. Pursuant to the Purchase Agreement, the Company shall use its best efforts to obtain its shareholder approval to increase the number of authorized common stock to allow legal issuance of the Stock Consideration to Ing-Ming Lai no later than December 31, 2019. In addition, pursuant to the Purchase Agreement, the Company shall pay the Cash Consideration to Ing-Ming Lai if and only if the Company successfully completes an Initial Public Offering (the "IPO") of its common stock, with gross proceeds of no less than $5,000,000 USD. The Purchase Agreement contains the customary confidentiality provision, representations and warranties. The Purchase Agreement also provides for mutual indemnification clauses. A-Best is a Taipei-based company that designs magnetic resonance speakers.

In connection with the Purchase Agreement, on August 7, 2019, the Company, A-Best, and Ing Ming Lai entered into an Exclusive Sales Agreement (the "Exclusive Sales Agreement"), pursuant to which the Company is granted the right as the exclusive distributor to sell all of A-Best's products, including its Micro-ceramic magnetic resonance speakers in the world, and the right to use A-Best's trademarks and copyrights in connection with the sale of such products. The term of the Exclusive Sales Agreement shall be three (3) years from execution and be automatically renewed for another term of three (3) years unless one party gives the other parties a written notice of termination three (3) months before the end of the term.

In connection with the Purchase Agreement, on August 7, 2019, the Company and Ing-Ming Lai entered into a management agreement (the "Management Agreement"), pursuant to which the Company has agreed to maintain A-Best's existing operations and Ing-Ming Lai's positions as A-Best's President and Chief Executive Officer of A-Best, until A-Best's board of directors decides to terminate the terms of his positions. Pursuant to the Management Agreement, the Company shall also designate one individual to A-Best's board of directors, and A-Best's board of directors shall continue to maintain two director seats, where at least one of the two directors is designated by the Company until the Parties either reach a shareholder agreement or A-Best receives additional capital investment in equity or debt. The Management Agreement became effective upon execution. For more information about this transaction, the Purchase Agreement, the Exclusive Sales Agreement and Management Agreement, please refer to the current report on Form 8-K which was filed with the Securities and Exchange Commission on August 13, 2019.

On December 30, 2019, the Company, A-Best, and Ing-Ming Lai, a Taiwanese individual and the majority shareholder of A-Best, entered into a termination agreement (the "Termination Agreement") to, among other things, terminate the Purchase Agreement, Exclusive Sales Agreement, and Management Agreement, all of which were dated August 7, 2019. The Company, A-Best and Mr. Ing-Ming Lai decided to terminate the three agreements primarily because they need more time to agree to a mutually beneficial way to cooperate with each other with respect to the sales of the Micro-ceramic magnetic resonance speakers that A-Best has developed. Pursuant to the Termination Agreement which became effective on December 31, 2019, none of the three parties owes any compensation, payments, damages, penalties or liabilities to one another or has any obligations to perform under any of the Purchase Agreement, Exclusive Sales Agreement, and Management Agreement, except that each party agrees to keep confidential the business plans, research and development information obtained from performing the three agreements. For more information about the Termination Agreement, please refer to the current report on Form 8-K which was filed with the Securities and Exchange Commission on December 31, 2019.

On March 2, 2020, the Company, A-Best, and Ing-Ming Lai, a Taiwanese individual and the majority shareholder of A-Best (collectively, the "Parties") entered into a strategic alliance agreement (the "Strategic Alliance Agreement"), pursuant to which the Parties redefined their cooperation with respect to the sales and distribution of A-Best's micro-ceramic speakers. In accordance with the Strategic Alliance Agreement, A-Best, Mr. Ing-Ming Lai and the Company terminated the Investment Cooperation Agreement dated January 12, 2019 entered by and among the Parties and as a result the Company agreed to return 20% of the equity interest in A-Best to Mr. Ing-Ming Lai, which was valued at approximately $35,142 by the Parties.

Furthermore, subject to the terms and conditions of the Strategic Alliance Agreement, A-Best has granted the Company the exclusive sale and distribution right of A-Best's micro-ceramic speakers in the world for one (1) year (the "Term"), which may be renewed with mutual consent of the Parties two months prior to the expiration of the Term, while A-Best retains its own right to sell and distribute the micro-ceramic speakers on its own. In consideration for the exclusive distribution right of A-Best's speakers under the Strategic Alliance Agreement, the Company agreed to have A-Best keep the Company's 10,000,000 shares of common stock, par value $0.001 per share, issued under the Investment Cooperation Agreement and the Company may keep the revenue and profits generated from the sale of A-Best speakers until the total revenue from such speakers reaches $15 million U.S. dollars. This Strategic Alliance Agreement contains A-Best's and Mr. Ing-Ming Lai's joint representation regarding their intellectual property rights to A-Best ceramic speakers. For more information about this transaction and the Strategic Alliance Agreement, please refer to the current report on Form 8-K which was filed with the Securities and Exchange Commission on March 5, 2020.



 14


  Table of Contents

On November 25, 2019, the Company and Ultra Velocity Technology Ltd. ("Ultra Velocity"), a corporation formed under the laws of Taiwan, entered into an exclusive patent licensing and distribution agreement (the "Exclusive Patent Licensing and Distribution Agreement"), pursuant to which, subject to the terms and conditions therein, Ultra Velocity granted the Company an exclusive license to the patent (Patent M566970 registered in Taiwan) to its electrical noise suppressing device (the "Calibrator") and the exclusive right to market, promote, distribute and sell the Calibrator globally. In accordance with the Agreement and in consideration for the exclusive patent license and distribution right to the Calibrator, the Company agreed to issue Ultra Velocity three million (3,000,000) restricted shares of its common stock after the execution of this Agreement and upon the shareholder approval to increase the number of authorized capital of the Company (the "Shareholder Approval"). The term of this Agreement was ten years, commencing from the dare thereof. However, on March 30, 2020, the Company and Ultra Velocity terminated the Exclusive Patent Licensing and Distribution Agreement via a mutually agreed written notice, effective March 24, 2020.



On
M
arch
2, 2020, the
Company returned 20% equity interest in A-Best to Mr. Ing-Ming Lai pursuant to
the Strategic Alliance Agreement.
On April 12, 2021, the Company, A-Best, and Ing-Ming Lai, a Taiwanese individual
and the majority shareholder of A-Best, entered into a termination agreement
(the "Termination Agreement") to terminate the agreement of Strategic Alliance
Agreement (the "Strategic Alliance Agreement") dated March 2, 2020. In the
agreement, Ing-Ming Lai has proceed to effect a return of a total of 10,000,000
shares in EOS INC, back to the company.

The Board of Directors of this Corporation authorized the return of the 10,000,000 EOSS shares from Ing Ming Lai.

Distribution Agreements and Supply Agreement

On May 1, 2015, we entered into a written Distribution Agreement with A.C. (USA), Inc. ("A.C.") pursuant to which we have an exclusive right to market and distribute in Taiwan certain skin care products manufactured by A.C. for a period of 5 years (the "Distribution Agreement"). Pursuant to the provisions of the Distribution Agreement, we will market and promote the A.C. Products as defined therein in Taiwan. Accordingly, we are the exclusive distributor for those A.C. Products in Taiwan.

On April 30, 2018, we, through our Emperor Star, entered into a distribution agreement (the "Cosminergy Distribution Agreement") with Cosminergy Hitech Development Co., Ltd. (Cosminergy") pursuant to which we started purchasing a type of water purifying machines from Cosminergy and reselling the water purifying machines in certain Asian areas and countries. The Cosminergy Distribution Agreement expired on April 30, 2019 and we did not renew it.

We, through one of our wholly-owned subsidiaries, entered into a product supply agreement ("Fortune King Product Supply Agreement") with Fortune King (HK) Trading Limited ("Fortune King"), a company formed under the laws of Hong Kong, to provide and sell any products that Fortune King orders from EOS and its subsidiaries. Pursuant to the Fortune King Product Supply Agreement, we agreed to provide products ordered by Fortune King within five business days from the order date and the products we sell should have the expiration date/shelf life at least one year from the supply date. The Fortune King Product Supply Agreement became effective on October 1, 2018 and was extended to September 30, 2021. We provide marketing information on the products we sell and training services to Fortune King. During the year ended December 31, 2018 and nine months ended September 30, 2019, the majority of EOS' sales of Nine Layer Transformation Hair Cream, Deep Seawater Mineral Extract, Lifegenes, Youthgenes, and household water purifying machines were to Fortune King. As of June 30, 2019, Fortune King was a related party of us because the founder and officer of Fortune King was a shareholder of EOS. On or about June 30, 2019, the founder and officer of Fortune King transferred her equity interest in the Company and therefore Fortune King is no longer a related party to the Company.

Critical Accounting Policies and Estimates

Principles of Consolidation

The accompanying audited consolidated financial statements, including the accounts of EOS Inc. and its wholly owned subsidiaries in Taiwan, British Virgin Islands, and People's Republic of China, have been prepared in conformity with accounting principles generally accepted in the United States of America. Since the Company and Emperor Star are entities under common control prior to the acquisition of Emperor Star, the transaction is accounted for as a restructuring transaction. All the assets and liabilities of Emperor Star were transferred to the Company at their respective carrying amounts on the date of transaction. The Company has recast prior period financial statements to reflect the conveyance of Emperor Star's common shares as if the restructuring transaction had occurred as of the earliest date of the financial statements. All material intercompany accounts, transactions, and profits have been eliminated in consolidation. The nature of and effects on earnings per share (EPS) of nonrecurring intra-entity transactions involving long-term assets and liabilities is not required to be eliminated and EPS amounts have been recast to include the earnings (or losses) of the transferred net assets.



 15


  Table of Contents

The functional currency of the subsidiaries in Taiwan is the New Taiwan dollars and the subsidiary in People's Republic of China is the Chinese Yuan, or Renminbi; however, the accompanying unaudited consolidated financial statements have been translated and presented in United States Dollars ($). In the accompanying unaudited consolidated financial statements and notes, "$", "US$" and "U.S. dollars" mean United States dollars, "NT$" and "NT dollars" mean New Taiwan dollars, and "RMB" means Chinese Yuan, or Renminbi.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.



 16


  Table of Contents

Impairment of Long-Lived Assets

The Company has adopted Accounting Standards Codification subtopic 360-10, Property, Plant and Equipment ("ASC 360-10"). ASC 360-10 requires that long-lived assets and certain identifiable intangibles held and used by the Company be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company evaluates its long-lived assets for impairment annually or more often if events and circumstances warrant. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve breakeven operating results over an extended period. The Company evaluates the recoverability of long-lived assets based upon forecasted undiscounted cash flows. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted, based on estimates of future discounted cash flows resulting from the use and ultimate disposition of the asset. ASC 360-10 also requires assets to be disposed of be reported at the lower of the carrying amount or the fair value less costs to sell. Management has determined that no impairments of long-lived assets currently exist as of December 31, 2021 and 2020.

Long-term Equity Investment

The Company acquires equity investment to promote business and strategic objectives. The Company accounts for non-marketable equity and other equity investments for which the Company does not have control over the investees as:



?   Equity method investments when the Company has the ability to exercise
    significant influence, but not control, over the investee. Its proportionate
    share of the income or loss is recognized monthly and is recorded in gain
    (loss) on equity investments.

?   Non-marketable cost method investments when the equity method does not apply.


Significant judgment is required to identify whether an impairment exists in the valuation of the Company's non-marketable equity investments, and therefore the Company considers this a critical accounting estimate. Its yearly analysis considers both qualitative and quantitative factors that may have a significant impact on the investee's fair value. Qualitative analysis of its investments involves understanding the financial performance and near-term prospects of the investee, changes in general market conditions in the investee's industry or geographic area, and the management and governance structure of the investee. Quantitative assessments of the fair value of its investments are developed using the market and income approaches. The market approach includes the use of comparable financial metrics of private and public companies and recent financing rounds. The income approach includes the use of a discounted cash flow model, which requires significant estimates regarding the investees' revenue, costs, and discount rates. The Company's assessment of these factors in determining whether an impairment exists could change in the future due to new developments or changes in applied assumptions.

Other-Than-Temporary Impairment

The Company's long-term equity investments are subject to a periodic impairment review. Impairments affect earnings as follows:



?   Marketable equity securities include the consideration of general market
    conditions, the duration and extent to which the fair value is below cost,
    and our ability and intent to hold the investment for a sufficient period of
    time to allow for recovery of value in the foreseeable future. The Company
    also considers specific adverse conditions related to the financial health
    of, and the business outlook for, the investee, which may include industry
    and sector performance, changes in technology, operational and financing cash
    flow factors, and changes in the investee's credit rating. The Company
    records other-than-temporary impairments on marketable equity securities and
    marketable equity method investments in gain (loss) on equity investments.

?   Non-marketable equity investments based on the Company's assessment of the
    severity and duration of the impairment, and qualitative and quantitative
    analysis of the operating performance of the investee; adverse changes in
    market conditions and the regulatory or economic environment; changes in
    operating structure or management of the investee; additional funding
    requirements; and the investee's ability to remain in business. A series of
    operating losses of an investee or other factors may indicate that a decrease
    in value of the investment has occurred that is other than temporary and that
    shall be recognized even though the decrease in value is in excess of what
    would otherwise be recognized by application of the equity method. A loss in
    value of an investment that is other than a temporary decline shall be
    recognized. Evidence of a loss in value might include, but would not
    necessarily be limited to, absence of an ability to recover the carrying
    amount of the investment or inability of the investee to sustain an earnings
    capacity that would justify the carrying amount of the investment. The
    Company records other-than-temporary impairments for non-marketable cost
    method investments and equity method investments in gain (loss) on equity
    investments.



Revenue Recognition


 17


  Table of Contents


Pursuant to ASC 606, the Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines is within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration the Company is entitled to in exchange for the goods or services the Company transfers to the customers. At inception of the contract, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract, determines those that are performance obligations, and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.

Merchandise sales: The Company recognizes sales revenues from merchandise sales when customers obtain control of the Company's products, which typically occurs upon delivery to customer. Merchandise sales revenues are recorded at the sales price, or "transaction price".

Software sales: The Company does not develop the software products on its own. When the Company receives a purchase order from the customer, the Company would engage with the third-party software company to customize and develop the software products. The Company recognizes software revenues upon completion of the installation and testing, and transfer the control of the software products to the customer. Software revenues are recorded at the fixed sales price, or "transaction price", pursuant to the sales contracts. The Company may also charge the customer maintenance service fees on a straight-line basis over the service period pursuant to the sales contract. The Company concluded that the performance obligation for the maintenance service is distinct. Therefore, such maintenance service revenue can be separated from other elements in the arrangement.

Trade discount and allowances: The Company generally does not provide invoice discounts on product sales to its customers for prompt payment.



Product returns
:
The Company generally does not provide customers with the right to return a
product for a full or partial refund, a credit, or an exchange for another
product.

To date, product allowance and returns have been minimal and, based on its experience, the Company believes that returns of its products will continue to be minimal.

The following tables provide details of revenue by major products and by geography.

Revenue by Major Products



For the year ended December 31, 2021:
Nutrition supplement                    $  68,840
Water purifier machine                    107,826
Automobile carbon reduction machine       305,868
Software                                   35,953
 Total                                  $ 518,487


For the year ended December 31, 2020:
Nutrition supplement                    $    73,317
Water purifier machine                    1,376,795
Automobile carbon reduction machine         400,061
Software                                     87,613
 Total                                  $ 1,937,786



Revenue by Geography

For the year ended December 31, 2021:
Asia Pacific                            $ 518,487
Total                                   $ 518,487


For the year ended December 31, 2020:
Asia Pacific                            $ 1,937,786
Total                                   $ 1,937,786



Leases

The Company adopted FASB Accounting Standards Codification, Topic 842, Leases ("ASC 842") using the modified retrospective approach, electing the practical expedient that allows the Company not to restate its comparative periods prior to the adoption of the standard on January 1, 2019. As such, the disclosures required under ASC 842 are not presented for periods before the date of adoption. For the comparative periods prior to adoption, the Company presented the disclosures which were required under ASC 840.



 18


  Table of Contents

The new leasing standard requires recognition of leases on the consolidated balance sheets as right-of-use ("ROU") assets and lease liabilities. ROU assets represent the Company's right to use underlying assets for the lease terms and lease liabilities represent the Company's obligation to make lease payments arising from the leases. Operating lease ROU assets and operating lease liabilities are recognized based on the present value and future minimum lease payments over the lease term at commencement date. The Company's future minimum based payments used to determine the Company's lease liabilities mainly include minimum based rent payments. As most of Company's leases do not provide an implicit rate, the Company uses its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. In addition, the adoption of the standard did not have a material impact on the Company's results of operations or cash flows. Operating lease cost is recognized as a single lease cost on a straight-line basis over the lease term and is recorded in Selling, general and administrative expenses. Variable lease payments for common area maintenance, property taxes and other operating expenses are recognized as expense in the period when the changes in facts and circumstances on which the variable lease payments are based occur.

Advertising Costs

Advertising costs are expensed at the time such advertising commences. Advertising expenses were $399 and $22,840 for the year ended December 31, 2021 and 2020, respectively.

Post-retirement and Post-employment Benefits

The Company's subsidiaries in Taiwan adopted the government mandated defined contribution plan pursuant to the Taiwan Labor Pension Act (the "Act"). Such labor regulations require that the rate of contribution made by an employer to the Labor Pension Fund per month shall not be less than 6% of the worker's monthly salaries. Pursuant to the Act, the Company makes monthly contribution equal to 6% of employees' salaries to the employees' pension fund. The Company has no legal obligation for the benefits beyond the contributions made. The total amounts for such employee benefits, which were expensed as incurred, were $5,873 and $5,377 for the year ended December 31, 2021 and 2020, respectively. Other than the above, the Company does not provide any other post-retirement or post-employment benefits.




 19



  Table of Contents


Fair Value Measurements

FASB ASC 820, "Fair Value Measurements" defines fair value for certain financial and nonfinancial assets and liabilities that are recorded at fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. It requires that an entity measure its financial instruments to base fair value on exit price, maximize the use of observable units and minimize the use of unobservable inputs to determine the exit price. It establishes a hierarchy which prioritizes the inputs to valuation techniques used to measure fair value. This hierarchy increases the consistency and comparability of fair value measurements and related disclosures by maximizing the use of observable inputs and minimizing the use of unobservable inputs by requiring that observable inputs be used when available. Observable inputs are inputs that reflect the assumptions market participants would use in pricing the assets or liabilities based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company's own assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy prioritizes the inputs into three broad levels based on the reliability of the inputs as follows:

? Level 1 - Inputs are quoted prices in active markets for identical assets or

liabilities that the Company has the ability to access at the measurement date.

Valuation of these instruments does not require a high degree of judgment as

the valuations are based on quoted prices in active markets that are readily

and regularly available.

? Level 2 - Inputs other than quoted prices in active markets that are either

directly or indirectly observable as of the measurement date, such as quoted

prices for similar assets or liabilities; quoted prices in markets that are not

active; or other inputs that are observable or can be corroborated by

observable market data for substantially the full term of the assets or

liabilities.

? Level 3 - Valuations based on inputs that are unobservable and not corroborated

by market data. The fair value for such assets and liabilities is generally

determined using pricing models, discounted cash flow methodologies, or similar

techniques that incorporate the assumptions a market participant would use in

pricing the asset or liability.

The carrying values of certain assets and liabilities of the Company, such as cash and cash equivalents, accounts receivable, inventory, advance to suppliers, prepaid expenses, accounts payable, accrued expenses, and due to shareholders, approximate fair value because of to their relatively short maturities.

Net Income Per Share

Basic income per share is computed by dividing net income by weighted average number of shares of common stock outstanding during each period. Diluted income per share is computed by dividing net income by the weighted average number of shares of common stock, common stock equivalents, and potentially dilutive securities outstanding during each period.

Income Taxes

The Company accounts for income taxes in accordance with ASC 740, Income Taxes, which requires that the Company recognize deferred tax liabilities and assets based on the differences between the financial statement carrying amounts and the tax basis of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse. Deferred income tax benefit (expense) results from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is recorded when, in the opinion of management, it is more likely than not that some or all of any deferred tax assets will not be realized.

Concentration of Credit Risk

Cash and cash equivalents : The Company's financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents. The Company places its cash and temporary cash investments in high quality credit institutions in Taiwan, but these investments may be in excess of the insurance limits of Taiwan Central Deposit Insurance Corporation (the "TCDIC"). The Company does not enter into financial instruments for hedging, trading or speculative purposes. Concentration of credit risk with respect to trade and notes receivables is limited due to the wide variety of customers and markets in which the Company transacts business, as well as their dispersion across many geographical areas. As of December 31, 2021, the Company had approximately $13,916 in excess of TCDIC insured limits. The Company has not experienced any losses in such accounts.

Customers

: The Company performs ongoing credit evaluations of its customers' financial condition and generally requires no collateral.



 20


  Table of Contents


For the year ended December 31, 2021, two customers accounted for more than 10%
of the Company's total revenues, representing approximately 56% and 39% of its
total revenues, and 84% and 11% of accounts receivable in aggregate at December
31, 2021.

            Net sales for the year          Accounts receivable
                     ended                        balance
Customer       December 31, 2021          as of December 31, 2021
   A       $                 290,749     $                 382,189
   B       $                 204,018     $                 134,655


For the year ended December 31, 2020, one customer accounted for more than 10% of the Company's total revenues, representing approximately 88% of its total revenues, and 95% of accounts receivable in aggregate at December 31, 2020.



            Net sales for the year        Accounts receivable
                     ended                      balance
Customer       December 31, 2020         as of December, 2020
   A       $               1,714,737     $           1,054,412



Suppliers

: The Company's inventory is purchased from various suppliers.

For the year ended December 31, 2021, three suppliers accounted for more than 10% of the Company's total net purchase, representing approximately 26%, 57% and 10% of total net purchase, and 0% of accounts payable in aggregate at December 31, 2021, respectively:



            Net purchase for the year
                      ended                Accounts payable balance
Supplier        December 31, 2021           as of December 31, 2021
   A       $                         -     $                       -
   B       $                    32,876     $                       -
   C       $                         -     $                       -
   D       $                         -     $                       -
   E       $                    71,505     $                       -
   F       $                    12,893     $                       -



For the year ended December 31, 2020, four suppliers accounted for more than 10% of the Company's total net purchase, representing approximately 45%, 27%, 13% and 12% of total net purchase, and 0%, 98%, 0% and 0% of accounts payable in aggregate at December 31, 2020, respectively:



            Net purchase for the year
                      ended                 Accounts payable balance
Supplier        December 31, 2020           as of December 31, 2020
   A       $                   182,634     $                        -
   B       $                   108,404     $                   18,079
   C       $                    50,927     $                        -
   D       $                    49,230     $                        -



 21



  Table of Contents



Foreign-currency Transactions

Foreign-currency transactions are recorded in New Taiwan dollars ("NTD") and Renminbi ("RMB") at the rates of exchange in effect when the transactions occur. Gains or losses resulting from the application of different foreign exchange rates when cash in foreign currency is converted into New Taiwan dollars and Renminbi, or when foreign-currency receivables or payables are settled, are credited or charged to income in the year of conversion or settlement. On the balance sheet dates, the balances of foreign-currency assets and liabilities are restated at the prevailing exchange rates and the resulting differences are charged to current income except for those foreign currencies denominated investments in shares of stock where such differences are accounted for as translation adjustments under stockholders' equity.

Translation Adjustment

The accounts of the Company's subsidiaries were maintained, and their financial statements were expressed in New Taiwan Dollar ("NTD") and Renminbi ("RMB"). Such financial statements were translated into U.S. Dollars ("$" or "USD") in accordance ASC 830, "Foreign Currency Matters", with the NTD and RMB as the functional currency. According to the Statement, all assets and liabilities are translated at the current exchange rate, common stock and additional paid-in capital are translated at the historical rates, and income statement items are translated at an average exchange rate for the period. The resulting translation adjustments are reported under accumulated other comprehensive income (loss) as a component of stockholders' equity.

Comprehensive Income (loss)

Comprehensive income (loss) includes accumulated foreign currency translation gains and losses. The Company has reported the components of comprehensive income (loss) on its consolidated statements of operations and other comprehensive income (loss).

Recent Accounting Pronouncements

In June 2016, the FASB issued ASU 2016-13, "Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments." This pronouncement, along with subsequent ASUs issued to clarify provisions of ASU 2016-13, changes the impairment model for most financial assets and will require the use of an "expected loss" model for instruments measured at amortized cost. Under this model, entities will be required to estimate the lifetime expected credit loss on such instruments and record an allowance to offset the amortized cost basis of the financial asset, resulting in a net presentation of the amount expected to be collected on the financial asset. In developing the estimate for lifetime expected credit loss, entities must incorporate historical experience, current conditions, and reasonable and supportable forecasts. This pronouncement is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2019. On November 19, 2019, the FASB issued ASU No. 2019-10, Financial Instruments-Credit Losses (Topic 326), finalized various effective date delays for private companies, not-for-profit organizations, and certain smaller reporting companies applying the credit losses (CECL), the revised effective date is January 2023.

Results of Operations

The following presents the consolidated results of the Company for the years ended December 31,2021 and December 31,2020.



Net Revenue
:

Net revenue was $518,487 for the year ended December 31, 2021, representing a decrease of $1,419,299, or 73%, as compared to $1,937,786 for the year ended December 31, 2020. The decrease was primarily due to the impact of the epidemic, the sales revenue of water purifier machine decreased compared with the prior year.



 22



  Table of Contents


Cost of Sales
:

Cost of sales was $312,951 for the year ended December 31, 2021, representing an increase of $4,643 or 2%, as compared to $308,308 for the year ended December 31, 2020. Such increase was mainly due to the increase in the sales of automobile carbon reduction machine. The automobile carbon reduction machines will come at a high cost to the company.



Gross Profit
:

Gross profit was $205,536 for the year ended December 31, 2021, compared to $1,629,478 for the same period in 2020. Gross profit as a percentage of net sales was 40% for the year ended December 31, 2021, compared to 84% in the same period in 2020. The change in gross margin was because s ales of products with higher gross margins decreased, resulting in lower gross margins.




Selling, General and Administrative Expenses
:

Selling, general and administrative expenses consist primarily of office rent,
salary and related costs for personnel and facilities, and professional service
fees. Selling, general and administrative expenses were $1,274,616 for the year
ended December 31, 2021, representing
de
crease of $1,097,058 or 46%, as compared to $2,371,674 for the year ended
December 31, 2020. The decrease in selling, general and administrative expenses
was primarily attributable to the decrease in bad debt expense.

Income (Loss) from Operations:



Loss from operations was $1,069,080 for the year ended December 31, 2021
compared to loss from operations of $742,196 for the year ended December 31,
2020, representing a
n
increase of $326,884 or 44%. Such increase was primarily due to the decrease in
sales.

Other Income (expenses):

Other loss was $15,893 for the year ended December 31, 2021, reflecting an increase of $3,199 or 25%, compared to other loss of $12,694 for the year ended December 31, 2020. The increase was mainly attributable to the increase in loss of foreign currency exchange.




Net Income (Loss):

As a result of the above factors, we had net loss was $1,101,565 for the year ended December 31, 2021, as compared to net in of $771,147 for the year ended December 31, 2020, representing an increase in loss of $330,418 or 43%.

Liquidity and Capital Resources

Cash and cash equivalents were $24,141 at December 31, 2021 and $122,482 at December 31, 2020. Our total current assets were $2,037,901 at December 31, 2021, as compared to $2,784,433 at December 31, 2020. Our total current liabilities were $792,118 at December 31, 2021, as compared to $ 529,030 at December 31, 2020.


 23


  Table of Contents


We had a working capital of $1,245,783 on December 31, 2021, compared to the
working capital of $
2,255,403
on December 31, 2020. The increase in working capital was primarily attributable
to the security deposit reclassify to current asset and
decrease in accounts payable
.

Net cash used in operating activities was $194,254 during the year ended
December 31, 2021, as compared to $
362,441
for the year ended December 31, 2020. The decrease in net cash used in operating
activities in the amount of $
168,193
was primary attributable to the decrease in security deposits and other assets
and account payable, partially offset by the increase in net income and advance
to suppliers.



Net cash used in investing activities was $352 during the year ended December 31, 2021, as compared to $2,218 for the year ended December 31, 2020. The decrease in net cash used in investing activities was due to the slight decrease in the acquisition of property, plant and equipment.

Net cash provided by financing activities was $95,271 during the year ended December 31, 2021, as compared to $199,966 for the year ended December 31, 2020. The decrease in net cash provided by financing activities was due to the repayment to related party payable and proceeds from borrowing.

Net change in cash and cash equivalents was a decrease of $98,341 for the year ended December 31, 2021, as compared to $173,112 for the year ended December 31, 2020.

Off-Balance Sheet Arrangements

We did not have any off-balance sheet arrangements as of December 31, 2021.

© Edgar Online, source Glimpses